FDA Inspection 678981 — John Caton Jr

John Caton Jr — FEI 3008420267

The FDA completed an inspection of John Caton Jr on August 20, 2010 in Springfield, OR. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 7 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
August 20, 2010
Fiscal Year
2010
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Springfield, OR (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
722721 CFR 50.27(a)Consent form not approved/signed/dated
739221 CFR 50.25(a)(7)Whom to contact
749821 CFR 312.66Unanticipated problems
752621 CFR 312.62(a)Accountability records
753021 CFR 312.62(b)Case history records- inadequate or inadequate
754321 CFR 312.61Unauthorized recipients (investigator)
756021 CFR 312.60FD-1572, protocol compliance